Merck Sharp & Dohme Corp.;Alectos Therapeutics Inc.
发明人:
Chang, Jiang,Liu, Kun,McEachern, Ernest J.,Mu, Changwei,Shi, Feng,Vocadlo, David J.,Wang, Yaode,Wei, Zhongyong,Zhou, Yuanxi,Zhu, Yongbao
申请号：
AU2016202186
公开号：
AU2016202186A1
申请日:
2016.04.07
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016202186A120160428.pdf#####ABSTRACT OF THE DISCLOSURE The invention is directed to compounds for selectively inhibiting glycosidases, uses of the compounds and pharmaceutical compositions including the compounds, and methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, and/or accumulation or deficiency of O-GlcNAc.
